Differential effect of the benzophenanthridine alkaloids sanguinarine and chelerythrine on glycine transporters

Neurochemistry International

Volumn 58, Issue 6, 2011, Pages 641-647

  Jursky, Frantisek ^a   Baliova, Martina ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Alkaloid; Benzophenanthridine; Chelerythrine; Chelidonium majus; Glycine; GlyT1; GlyT2; Inhibitor; Neurotransmitter; Ouabain; Pain; PKC; Protein kinase C; Sanguinarine; Transporter

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); BERBERINE; CHELERYTHRINE; GLYCINE; GLYCINE TRANSPORTER; GLYCINE TRANSPORTER 1; GLYCINE TRANSPORTER 2; SANGUINARINE;

ANALGESIC ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL;

BENZOPHENANTHRIDINES; CELL LINE; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; ISOQUINOLINES;

CHELIDONIUM MAJUS; STROPHANTHUS GRATUS;

EID: 79953687936     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.02.001     Document Type: Article

References (58)

1. N. Aburai, M. Yoshida, M. Ohnishi, and K. Kimura Sanguinarine as a potent and specific inhibitor of protein phosphatase 2C in vitro and induces apoptosis via phosphorylation of p38 in HL60 cells Biosci. Biotechnol. Biochem. 74 2010 548 552
2. S. Ahmadi, S. Lippross, W.L. Neuhuber, and H.U. Zeilhofer PGE2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons Nat. Neurosci. 5 2002 34 40 (Pubitemid 34038780)
3. C. Aragon, and B. Lopez-Corcuera Structure, function and regulation of glycine neurotransporters Eur. J. Pharmacol. 479 2003 249 262 (Pubitemid 37377893)
4. M. Baliova, and F. Jursky Calcium dependent modification of distal C-terminal sequences of glycine transporter GlyT1 Neurochem. Int. 57 2010 254 261
5. M. Baliova, H. Betz, and F. Jursky Calpain-mediated proteolytic cleavage of the neuronal glycine transporter, GlyT2 J. Neurochem. 88 2004 227 232 (Pubitemid 38030225)
6. H. Betz Structure and function of inhibitory glycine receptors Q. Rev. Biophys. 25 1992 381 394 (Pubitemid 23078701)
7. O. Boussif, F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, and J.P. Behr A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. U. S. A. 92 1995 7297 7301
8. T.M. Bridges, R. Williams, and C.W. Lindsley Design of potent GlyT1 inhibitors: in vitro and in vivo profiles Curr. Opin. Mol. Ther. 10 2008 591 601
9. 3H]candesartan to the human angiotensin AT1 receptor Eur. J. Pharmacol. 458 2003 257 262 (Pubitemid 36013461)
10. J.A. Coull, D. Boudreau, K. Bachand, S.A. Prescott, F. Nault, A. Sik, P. De Koninck, and Y. De Koninck Transsynaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain Nature 424 2003 938 942 (Pubitemid 37051684)
11. J.A. Coull, S. Beggs, D. Boudreau, D. Boivin, M. Tsuda, K. Inoue, C. Gravel, M.W. Salter, and Y. De Koninck BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain Nature 438 2005 1017 1021 (Pubitemid 43093974)
12. T. Dohi, K. Morita, T. Kitayama, N. Motoyama, and N. Morioka Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain Pharmacol. Ther. 123 2009 54 79
13. V. Eulenburg, W. Armsen, H. Betz, and J. Gomeza Glycine transporters: essential regulators of neurotransmission Trends Biochem. Sci. 30 2005 325 333 (Pubitemid 40799051)
14. U. Gether, P.H. Andersen, O.M. Larsson, and A. Schousboe Neurotransmitter transporters: molecular function of important drug targets Trends Pharmacol. Sci. 27 2006 375 383 (Pubitemid 43977787)
15. R. Gilfillan, J. Kerr, G. Walker, and G. Wishart Glycine transporters and their inhibitors Top. Med. Chem. 4 2009 223 247
16. R.J. Harvey, U.B. Depner, H. Wässle, S. Ahmadi, C. Heindl, H. Reinold, T.G. Smart, K. Harvey, B. Schütz, O.M. Abo-Salem, A. Zimmer, P. Poisbeau, H. Welzl, D.P. Wolfer, H. Betz, H.U. Zeilhofer, and U. Müller GlyRα3: an essential target for spinal PGE2-mediated inflammatory pain sensitization Science 304 2004 884 887 (Pubitemid 38620190)
17. M.N. Helms, X.J. Chen, S. Ramosevac, D.C. Eaton, and L. Jain Dopamine regulation of amiloride-sensitive sodium channels in lung cells Am. J. Physiol. 290 2006 L710 L722
18. J.M. Herbert, J.M. Augereau, J. Gleye, and J.P. Maffrand Chelerythrine is a potent and specific inhibitor of protein kinase C Biochem. Biophys. Res. Commun. 172 1990 993 999
19. K.L. Holton, M.K. Loder, and H.E. Melikian Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization Nat. Neurosci. 8 2005 881 888
20. D.C Javitt Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification Curr. Opin. Drug Discov. Devel. 12 2009 468 478
21. J.W. Johnson, and P. Ascher Glycine potentiates the NMDA response in cultured mouse brain neurons Nature 325 1987 529 531 (Pubitemid 17056733)
22. N.W. Kleckner, and R. Dingledine Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes Science 241 1988 835 837
23. Q.R. Liu, B. López-Corcuera, S. Mandiyan, H. Nelson, and N. Nelson Cloning and expression of a spinal cord- and brain-specific glycine transporter with novel structural features J. Biol. Chem. 268 1993 22802 22808 (Pubitemid 23318342)
24. M. Lopus, and D. Panda The benzophenanthridine alkaloid sanguinarine perturbs microtubule assembly dynamics through tubulin binding A possible mechanism for its antiproliferative activity FEBS J. 273 2006 2139 2150
25. S. Maione, I. Marabese, F. Rossi, L. Berrino, E. Palazzo, and L. Trabace Effects of persistent nociception on periaqueductal gray glycine release Neuroscience 97 2000 311 316 (Pubitemid 30224769)
26. M. Maiti, R. Nandi, and K. Chaudhuri Sanguinarine: a monofunctional intercalation alkaloids FEBS Lett. 142 1982 280 284
27. M. Martina, Y. Gorfinkel, S. Halman, J.A. Lowe, P. Periyalwar, C.J. Schmidt, and R. Bergeron Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels J. Physiol. 557 2004 489 500 (Pubitemid 38807389)
28. M.A. Martins, A.P. Carobrez, and C.R. Tonussi Activation of dorsal periaqueductal gray by glycine produces long lasting hyponociception in rats without overt defensive behaviors Life Sci. 83 2008 118 121
29. J. Masson, C. Sagné, M. Hamon, and S. El Mestikawy Neurotransmitter transporters in the central nervous system Pharmacol. Rev. 51 1999 439 464 (Pubitemid 29420211)
30. M. Mezler, W. Hornberger, R. Mueller, M. Schmidt, W. Amberg, W. Braje, M. Ochse, H. Schoemaker, and B. Behl Inhibitors of GlyT1 affect glycine transport via discrete binding sites Mol. Pharmacol. 74 2008 1705 1715
31. N. Morioka, J.M. Abdin, K. Morita, T. Kitayama, Y. Nakata, and T. Dohi The regulation of glycine transporter GLYT1 is mainly mediated by protein kinase Ca in C6 glioma cells Neurochem. Int. 53 2008 248 254
32. K. Morita, N. Motoyama, T. Kitayama, N. Morioka, K. Kifune, and T. Dohi Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice J. Pharmacol. Exp. Ther. 326 2008 633 645
33. J.P. Mothet, A.T. Parent, H. Wolosker, R.O. Brady Jr., D.J. Linden, C.D. Ferris, M.A. Rogawski, and S.H. Snyder d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor Proc. Natl. Acad. Sci. U. S. A. 97 2000 4926 4931 (Pubitemid 30238659)
34. N. Nelson The family of Na+/Cl neurotransmitter transporters J. Neurochem. 71 1998 1785 1803
35. J. Nichols, K.D. Straub, and S. Abernathy Effect of sanguinarine, a benzophenanthridine alkaloid, on frog skin potential difference and short circuit current Biochim. Biophys. Acta 511 1978 251 258 (Pubitemid 8383466)
36. A. Panatier, D.T. Theodosis, J.P. Mothet, B. Touquet, L. Pollegioni, D.A. Poulain, and S.H. Oliet Glia-derived d-serine controls NMDA receptor activity and synaptic memory Cell 125 2006 775 784
37. B.J.R. Pitts, and L.R. Meyerson Inhibition of Na K-ATPase activity and ouabain binding by sanguinarine Drug Dev. Res. 1 1981 43 47
38. S.A. Prescott, T.J. Sejnowski, and Y. De Koninck Reduction of anion reversal potential subverts the inhibitory control of firing rate in spinal lamina I neurons: towards a biophysical basis for neuropathic pain Mol. Pain 2 2006 32
39. K. Sato, R. Adams, H. Betz, and P. Schloss Modulation of a recombinant glycine transporter (GLYT 1 b) by activation of protein kinase C J. Neurochem. 65 1995 1967 1973
40. T. Schmeller, B. Latz-Bruning, and M. Wink Biochemical activities of berberine, palmitate and sanguinarine mediating chemical defence against microorganism and herbivores Phytochemistry 44 1997 257 266 (Pubitemid 27087925)
41. A. Sedo, K. Vlasicová, P. Barták, R. Vespalec, J. Vicar, V. Simánek, and J. Ulrichová Quaternary benzo[c]phenanthridine alkaloids as inhibitors of aminopeptidase N and dipeptidyl peptidase IV Phytother. Res. 16 2002 84 87 (Pubitemid 34116704)
42. A.N. Shemon, R. Sluyter, A.D. Conigrave, and J.S. Wiley Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor Br. J. Pharmacol. 142 2004 1015 1019 (Pubitemid 39037051)
43. T. Shimazaki, A. Kaku, and S. Chaki d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats Psychopharmacology (Berl.) 209 2010 263 270
44. M.C. Shin, M.H. Jang, H.K. Chang, S. Lim, S.M. Han, H.J. Park, I. Shim, J.S. Lee, K.A. Kim, and C.J. Kim Modulation of Chelidonii herba on glycine-activated and glutamate-activated ion currents in rat periaqueductal gray neurons Clin. Chim. Acta 337 2003 93 101 (Pubitemid 37329805)
45. V. Simanek, R. Vespalec, A. Sedo, J. Ulrichova, and J. Vicar Quaternary benzo[c]phenanthridine alkaloids - biological activities M.P. Schneider, Chemical Probes in Biology. NATO Science Series, II. Mathematics, Physics and Chemistry - 129 2003 Kluwer Academic Publishers Dordrecht 245 254
46. M. Stiborova, V. Simanek, E. Frei, P. Hobza, and J. Ulrichova DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique Chem. Biol. Interact. 140 2002 231 242 (Pubitemid 35247461)
47. C. Sur, and G.G. Kinney Glycine transporter 1 inhibitors and modulation of NMDA receptor-mediated excitatory neurotransmission Curr. Drug Targets 8 2007 643 649 (Pubitemid 46785062)
48. M. Tanabe, K. Takasu, S. Yamaguchi, D. Kodama, and H. Ono Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment Anesthesiology 108 2008 929 937 (Pubitemid 351589490)
49. R. Verpoorte Antimicrobially active alkaloids M.F. Roberts, M. Wink, Alkaloids. Biochemistry, Ecology and Medicinal Applications 1998 Plenum Press New York 397 426
50. R. Vespalec, P. Bartak, V. Simanek, and M. Vlcková Electrophoretic investigation of interactions of sanguinarine and chelerythrine with molecules containing mercapto group J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 797 2003 357 366 (Pubitemid 37421317)
51. B.H. Wang, Z.X. Lu, and G.M. Polya Inhibition of eukaryote protein kinases by isoquinoline and oxazine alkaloids Planta Med. 63 1997 494 498 (Pubitemid 28035441)
52. K.J. Whitehead, S.M. Pearce, G. Walker, H. Sundaram, D. Hill, and N.G. Bowery Positive N-methyl-d-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo Neuroscience 126 2004 381 390 (Pubitemid 38780814)
53. M. Wink, T. Schmeller, and B. Latz-Brüning Modes of action of allelochemical alkaloids: interaction with neuroreceptors, DNA, and other molecular targets J. Chem. Ecol. 24 1998 1881 1937 (Pubitemid 28546056)
54. J. Wolff, and L. Knipling Antimicrotubule properties of benzophenanthridine alkaloids Biochemistry 32 1993 13334 13339 (Pubitemid 24005944)
55. H Wolosker NMDA receptor regulation by d-serine: new findings and perspectives Mol. Neurobiol. 36 2007 152 164 (Pubitemid 351360344)
56. B.S. Yilmaz, H. Ozbek, G.S. Citoglu, S. Ugras, I. Bayram, and E. Erdogan Analgesic and hepatoprotective effects of Chelidonium majus L. J. Fac. Pharm. Ankara 36 2007 9 12
57. H.U. Zeilhofer, and U.B. Zeilhofer Spinal dis-inhibition in inflammatory pain Neurosci. Lett. 437 2008 170 174
58. Y.H. Zhang, A. Bhunia, K.F. Wan, M.C. Lee, S.L. Chan, V.C. Yu, and Y.K. Mok Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft J. Mol. Biol. 364 3 2006 536 549 (Pubitemid 44715937)